Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Cogentix Medical

Request full access

A global medical device company that develops, manufactures, and markets products for the minimally invasive treatment of voiding dysfunctions and endoscopy solutions

Minnetonka, United StatesFounded 1987Health

About Cogentix Medical

The story of Cogentix Medical isn’t one of a typical startup, but a strategic combination of two existing med-tech players. In March 2015, Minnesota-based Uroplasty and New York's Vision-Sciences, founded by Lewis Pell, merged to form Cogentix Medical. The new entity, led by Uroplasty’s CEO Rob Kill, was established to diagnose and treat urologic conditions, combining Uroplasty’s devices for overactive bladder and incontinence with Vision-Sciences’ endoscopy systems. The goal was to create a larger, more robust company in the urology space. The newly formed Cogentix focused on key products like the Urgent PC Neuromodulation System, a non-drug treatment for overactive bladder, and the PrimeSight endoscopy line which utilized a sterile disposable barrier to improve safety and efficiency. However, the initial years following the merger were challenging, leading to a crucial turning point in 2016. A $25 million private equity investment from Accelmed and the conversion of debt held by co-founder Lewis Pell into equity were instrumental in keeping the company afloat and positioning it for future growth. This strategic reset paid off. By 2018, Cogentix Medical had become an attractive target. Laborie Medical Technologies, a Canadian company owned by the Swedish investment firm Investor AB, announced its intent to acquire Cogentix. The acquisition was finalized in April 2018 for approximately $214 million. This move integrated Cogentix's therapeutic devices into Laborie's broader urology portfolio, providing a comprehensive set of solutions from diagnosis to treatment. Following the acquisition, Cogentix Medical was delisted from the Nasdaq stock market, marking the end of its journey as an independent public company and its absorption into a larger global entity.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
34
Open positions
None listed
Dealroom signal
37.0/100
Industry
Health
Client focus
B2B
Investment activity
4 companies, latest Oct 2017
Capital deployed
$2M
Preferred round
ACQUISITION

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Mar 2018 $239M $239M Undisclosed —
GROWTH EQUITY VC✓Equity / VC Sep 2016 $25M — Accelmed —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Cogentix Medical website traffic

Latest recorded traffic for Cogentix Medical is 12K monthly website visits, up 242.9% over the last three months. Cogentix Medical's team grew 0% over the past year.

Latest monthly visits12K 3-month web change+242.9% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Cogentix Medical in the Minnetonka ecosystem

Live from Dealroom

The Cogentix Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • Accelmed
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Cogentix Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cogentix Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.